Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...

Emkay Global Financial is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its ...

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX® (bimekizumab-bkzx) is now available. These ...

Mizuho Securities analyst Uy Ear has maintained their bullish stance on ARQT stock, giving a Buy rating on January 13.Stay Ahead of the ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

UCB announced that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX is now available.

UCB SA (OTCMKTS:UCBJY – Get Free Report)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $96.49 and traded as low as $93.22.

However, most treatment guidelines were developed based ... Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. J Dermatol.

thanks to its oral dosing and efficacy that rivals the injectable treatments for moderate to severe plaque psoriasis. J&J is already preparing to go head-to-head with its rival. The company has ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable ... like not smoking tobacco. Before your next plaque surfaces and that unbearable ...